Company / Operating Income per Share
Catalyst Pharmaceuticals Partners, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.10
FY2025
5-year range
$0.51 / $2.10
FY2021-FY2025
Trend
+30.3%
vs FY2024
Sector context
#29 of 201
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s operating income per share of $2.10 is higher than 86% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-0.34 in FY2018 to $2.10 in FY2025.
Based on SEC 10-K filings.
2.10 in FY2025 with a 5-year CAGR of +39.4%. Top quartile in the Health Care sector.
Improved from $0.81 to $2.10 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +29.6%
- 5-Year CAGR
- +39.4%
- 10-Year CAGR
- -
Sector benchmark
+107.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 30.3% year-over-year.
- Ranks #29 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.10 | +30.3% |
| FY2024 | $1.61 | +99.2% |
| FY2023 | $0.81 | -16.2% |
| FY2022 | $0.97 | +90.2% |
| FY2021 | $0.51 | +27.3% |
| FY2020 | $0.40 | +29.0% |
| FY2019 | $0.31 | +190.0% |
| FY2018 | -$0.34 | -40.0% |
| FY2017 | -$0.25 | -5.8% |
| FY2016 | -$0.23 | +5.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026